- Home
- ACLX vs AMG Comparison
ACLX vs AMG Comparison
Compare ACLX & AMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACLX
- AMG
- Stock Information
- Founded
- ACLX 2015
- AMG 1993
- Country
- ACLX United States
- AMG United States
- Employees
- ACLX N/A
- AMG N/A
- Industry
- ACLX Biotechnology: Pharmaceutical Preparations
- AMG Investment Managers
- Sector
- ACLX Health Care
- AMG Finance
- Exchange
- ACLX Nasdaq
- AMG Nasdaq
- Market Cap
- ACLX 5.3B
- AMG 5.6B
- IPO Year
- ACLX 2022
- AMG 1997
- Fundamental
- Price
- ACLX $77.58
- AMG $187.49
- Analyst Decision
- ACLX Strong Buy
- AMG Buy
- Analyst Count
- ACLX 14
- AMG 5
- Target Price
- ACLX $107.67
- AMG $202.40
- AVG Volume (30 Days)
- ACLX 599.1K
- AMG 211.0K
- Earning Date
- ACLX 11-07-2024
- AMG 02-03-2025
- Dividend Yield
- ACLX N/A
- AMG 0.02%
- EPS Growth
- ACLX N/A
- AMG N/A
- EPS
- ACLX N/A
- AMG 15.64
- Revenue
- ACLX $155,818,000.00
- AMG $2,019,200,000.00
- Revenue This Year
- ACLX $12.58
- AMG $0.54
- Revenue Next Year
- ACLX N/A
- AMG $5.51
- P/E Ratio
- ACLX N/A
- AMG $11.99
- Revenue Growth
- ACLX 230.33
- AMG N/A
- 52 Week Low
- ACLX $47.88
- AMG $145.36
- 52 Week High
- ACLX $107.37
- AMG $199.52
- Technical
- Relative Strength Index (RSI)
- ACLX 39.00
- AMG 53.66
- Support Level
- ACLX $73.39
- AMG $178.32
- Resistance Level
- ACLX $90.23
- AMG $188.38
- Average True Range (ATR)
- ACLX 4.40
- AMG 3.79
- MACD
- ACLX -0.84
- AMG -0.11
- Stochastic Oscillator
- ACLX 24.90
- AMG 76.10
About ACLX Arcellx Inc.
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.
About AMG Affiliated Managers Group Inc.
Affiliated Managers Group offers investment strategies to investors through its network of affiliates. The firm typically buys a majority interest in small to midsize boutique asset managers, receiving a fixed percentage of revenue from these firms in return. Affiliates operate independently, with AMG providing strategic, operational, and technology support, as well as global distribution. At the end of December 2023, AMG's affiliate network—which includes firms like AQR Capital Management, and Pantheon in alternative assets and other products (which accounted for 35% of AUM), Artemis, Genesis, Harding Loevner, and Tweedy Browne in global and emerging-market equities (28%) and Frontier, River Road, Parnassus, and Yacktman in U.S. equities (21%)—had $672.2 billion in managed assets.